Last month’s performance of -31.18% for NRX Pharmaceuticals Inc (NRXP) is certainly impressive

Shaun Noe

NRX Pharmaceuticals Inc (NASDAQ: NRXP) kicked off on Friday, down -8.24% from the previous trading day, before settling in for the closing price of $2.67. Over the past 52 weeks, NRXP has traded in a range of $1.12-$6.01.

While this was happening, its average annual earnings per share was recorded 74.51%. With a float of $20.88 million, this company’s outstanding shares have now reached $23.77 million.

NRX Pharmaceuticals Inc (NRXP) Insider and Institutional Ownership

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of NRX Pharmaceuticals Inc is 12.16%, while institutional ownership is 26.17%. The most recent insider transaction that took place on Dec 17 ’24, was worth 46,800. In this transaction Chairman and Chief Scientist of this company bought 40,000 shares at a rate of $1.17, taking the stock ownership to the 84,634 shares.

NRX Pharmaceuticals Inc (NRXP) Latest Financial update

In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.15 earnings per share (EPS), higher than consensus estimate (set at -0.66) by 0.51. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.

NRX Pharmaceuticals Inc (NASDAQ: NRXP) Trading Performance Indicators

Take a look at NRX Pharmaceuticals Inc’s (NRXP) current performance indicators. Last quarter, stock had a quick ratio of 0.11.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.24, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.79 in one year’s time.

Technical Analysis of NRX Pharmaceuticals Inc (NRXP)

The latest stats from [NRX Pharmaceuticals Inc, NRXP] show that its last 5-days average volume of 0.52 million was superior to 0.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 3.80%.

During the past 100 days, NRX Pharmaceuticals Inc’s (NRXP) raw stochastic average was set at 12.03%, which indicates a significant increase from 1.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.21 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.02, while its 200-day Moving Average is $2.70. Now, the first resistance to watch is $2.62. This is followed by the second major resistance level at $2.79. The third major resistance level sits at $2.88. If the price goes on to break the first support level at $2.36, it is likely to go to the next support level at $2.27. The third support level lies at $2.10 if the price breaches the second support level.

NRX Pharmaceuticals Inc (NASDAQ: NRXP) Key Stats

The company with the Market Capitalisation of 58.24 million has total of 19,810K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -25,130 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -17,580 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.